Access cutting-edge lung cancer treatment through this clinical trial at a research site in Colorado Springs. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Colorado Springs at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab alone in participants with advanced or metastatic non-small cell lung cancer (NSCLC) of non-squamous histology.
Sponsor: Daiichi Sankyo
Check if you qualify for this lung cancer clinical trial in Colorado Springs, CO
If you're searching for lung cancer treatment options in Colorado Springs, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Colorado Springs research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.